CD274 and neoplasm: In addition, the combination of the oncolytic T-01 virus with the anti-programmed cell death ligand 1 (PD-L1) antibody, increased the number of tumor-specific T-cells in the tumor microenvironment, as it was demonstrated in a TC-1 murine model [109].